3268
K. Mori, T. Tashiro / Tetrahedron Letters 50 (2009) 3266–3269
The final step as depicted in Scheme 5 was the esterification of
a
c
b
the four stereoisomers of the acid 17 with (S)-20. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC, 1.6
equiv) was added to a solution of (3R,13R)-17 (1 equiv), (S)-20
(2 equiv), and 4-(N,N-dimethylamino)pyridine (DMAP, 1.9 equiv)
OH
O
( )-18
19
in dichloromethane to give (3R,13R,10S)-1 as an oil, ½a 2D3
ꢀ5.38 (c
ꢁ
1.30, CHCl3), in 83% yield. Its 1H and 13C NMR data18 are in good ac-
cord with those published for (3RS,13RS,10S)-1.1 The MS of
(3R,13R,10S)-118 was also in accord with that of the naturally occur-
ring pheromone component 1.1 Similarly, we synthesized (3R,
+
OH
OH
O
(R)-18
(S)-20
21
(96% ee)
(94% ee)
13S,10S)-1, ½a 2D3
ꢁ
+1.63 (c 1.32, CHCl3), (3S,13R,10S)-1, ½a D23
ꢀ10.8 (c
ꢁ
1.31, CHCl3), and (3S,13S,10S)-1, ½a D23
ꢀ3.42 (c l.20, CHCl3). The
ꢁ
e
d
B
spectral data of these four isomers of 1 were virtually indistin-
guishable.18 The overall yield of (3R,13R,10S)-1 was 13% based on
(R)-10 (12 steps).
(R)-Alpine-Borane®
OBz
O(R)-MTPA
O
C
OMe
C
(R)-22
(S)-23
3. Conclusion
CF3
We synthesized all of the four stereoisomers of (10S)-1-ethyl-2-
methylpropyl 3,13-dimethylpentadecanoate (1), the major compo-
nent of the sex pheromone of C. variegata. Future bioassay of these
four stereoisomers of 1 will hopefully clarify the absolute configu-
ration of the naturally occurring and bioactive component 1. Olefin
cross metathesis has been shown to be a useful reaction in phero-
mone synthesis, especially when a set of stereoisomers has to be
prepared quickly and efficiently.
MTPA
Scheme 4. Synthesis of the alcohol (S)-20. Reagents: (a) Jones CrO3, acetone (73%);
(b) (R)-Alpine-BoraneÒ (47%); (c) H2, 10% Pd–C, pentane (83%); (d) BzCl, DMAP,
C5H5N; (e) (S)-MTPACl, C5H5N.
O
a
CO2H
(CH2)9
(CH2)9
O
Acknowledgments
(3R,13R)-17
(3R,13R,1'S)-1
K.M. thanks Mr. M. Kimura (president, Toyo Gosei Co., Ltd) for
his support. Our thanks are due to Mr. Y. Shikichi (Toyo Gosei
Co., Ltd) for GC–MS and NMR measurements, Dr. S. Tamogami
(T. Hasegawa Co.) for enantioselective GC analysis, Professor T.
Nakata (Tokyo University of Science) for his help in MS, and Dr.
K. Manabe (RIKEN) for his permission to use his GC apparatus. Both
(R)- and (S)-citronellal were supplied by Takasago International
Corporation, and (R)-2-methylbutanoic acid was supplied by T.
Hasegawa Co.
Similarly
+
+
+
(3R,13S,1'S)-1
(3S,13R,1'S)-1
(3S,13S,1'S)-1
OAc
OAc
OAc
(S)-8
(R)-8
(S)-8
(R)-12
(S)-12
(S)-12
References and notes
1. Gries, R.; Khaskin, G.; Tan, Z.-X.; Zhao, B.-G.; King, G. G. S.; Miroshnychenko, A.;
Lin, G.-Q.; Rhainds, M.; Gries, G. J. Chem. Ecol. 2006, 32, 1673–1685.
2. Mori, K. Bioorg. Med. Chem. 2007, 15, 7505–7523.
3. A totally different synthesis of the four isomers of 1 is recorded by Lin and his
co-workers in a patent literature without any spectral and chiroptical data of
the intermediates and final products: Wei, B.; Liu, R.; Zhang, C.; Sun, X.; Lin, G.-
q. Chinese Patent (Faming Zhuanli Shenqing Gongkai Shuomingshu) 2008, CN
101157613(A).
Scheme 5. Synthesis of the target esters 1. Reagents: (a) (S)-20, EDC, DMAP, CH2Cl2
[83% based on (3R,13R)-17].
yield of (3R,13R)-17 was 35% based on (R)-12 (4 steps). Other ster-
eoisomers of the acid 17 could be synthesized in the same manner.
The next task was the synthesis of (S)-2-methylpentan-3-ol
(20). Gries et al. previously prepared (S)-20 by kinetic resolution
of ( )-4-methyl-1-penten-3-ol by Sharpless asymmetric epoxida-
tion.1 As shown in Scheme 4, we synthesized (S)-20 by asymmetric
reduction of 4-methyl-1-pentyn-3-one (19) to (R)-18 with Brown’s
(R)-Alpine-BoraneÒ14 as the key step. Commercially available ( )-
4-methyl-1-pentyn-3-ol (18) was oxidized with Jones chromic acid
to give ketone 19. This was reduced with (R)-Alpine-BoraneÒ to
4. Hashimoto, H.; Tatehara, T.; Komai, T. Jpn. Kokai Tokkyo Koho P 2005-348727A.
5. Fouquet, C.; Schlosser, M. Angew. Chem., Int. Ed. 1974, 13, 82–83.
7
6. (a) GC analysis of (R)-8 [instrument: Agilent 7890; column: CHIRAMIX,Ò
30 m ꢂ 0.25 mm i.d.; column temp.: 40–180 °C (+0.7 °C/min); carrier gas: He,
0.7 mL/min]: tR 42 min (>99.9%, (R)-8], 47 min [<1.0%, (S)-8].; (b) GC analysis of
(S)-8 [same conditions as for (R)-8]: tR 42 min [0.5%, (R)-8], 47 min [99.5%, (S)-8].
7. Tamogami, S.; Awano, K.; Amaike, M.; Takagi, Y.; Kitahara, T. Flavour Frag. J.
2001, 16, 349–352.
9. (a) GC analysis of (R)-12 [instrument: Agilent 7890; column: 50% octakis-(2,3-
di-O-methoxymethyl-6-O-t-butyldimethylsilyl)-c-cyclodextrin,
30 m ꢂ 0.25 mm i.d.; column temp.: 40–180 °C (+0.7 °C/min); carrier gas: He,
0.7 mL/min]: tR 77 min [98.6%, (R)-12], 78 min [1.4%, (S)-12].; (b) GC analysis of
(S)-12 [same conditions as for (R)-12]: tR 77 min [1.4%, (R)-12], 78 min [98.6%,
(S)-12].
give highly volatile (R)-18, bp 119–121 °C, ½a D25
ꢀ 0:96 (c 1.37,
ꢁ
CHCl3), in 47% yield. The enantiomeric purity of (R)-18 was esti-
mated as 96% ee by HPLC analysis of the corresponding benzoate
(R)-22.15 Hydrogenation of (R)-18 over 10% palladium–charcoal
in pentane afforded a 2:1 mixture of (S)-20 and 21. After chromato-
graphic purification, highly volatile and pure (S)-20, bp 104–
10. Pederson, R. The Efficient Application of Olefin Metathesis in Pharmaceutical
and Fine Chemicals. Sigma–Aldrich CheminarÒ 4.1 (2008). (Sigma–
aldrich.com/cheminars).
11. Blackwell, H. E.; O’Leary, D. J.; Chatterjee, A. K.; Washenfelder, R. A.; Bussmann,
D. A.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 122, 58–71.
12. Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003,
125, 11360–11370.
13. Connon, S. J.; Blechert, S. Angew. Chem., Int. Ed. 2003, 42, 1900–1923.
14. Brown, H. C.; Pai, G. G. J. Org. Chem. 1985, 50, 1384–1394.
106 °C, ½a 2D5
ꢁ
ꢀ 14:0 (c 1.10, CHCl3), ½a D25
ꢀ 20:1 (c 1.16, EtOH), Ref.
ꢁ
16 ½a 2D3
ꢀ 16:9 (c 0.39, EtOH), could be secured in 16% yield. Its
ꢁ
enantiomeric purity was estimated as 94.2% ee by GC analysis of
the corresponding (R)-MTPA ester 23.17